{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:41:58Z","timestamp":1787002918964,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr &amp; Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Undiagnosed comorbid diseases that independently lead to weight loss before type 2 diabetes mellitus (T2DM) diagnosis could explain the observed increased mortality risk in T2DM patients with normal weight.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the impact of weight change patterns before the diagnosis of T2DM on the association between body mass index (BMI) at diagnosis and mortality risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a longitudinal cohort study using 145,058 patients from UK primary care, with newly diagnosed T2DM from January 2000. Patients aged 18\u201370, without established disease history at diagnosis (defined as the presence of cardiovascular diseases, cancer, and renal diseases on or before diagnosis) were followed up to 2014. Longitudinal 6-monthly measures of bodyweight three years before (used to define groups of patients who lost bodyweight or not before diagnosis) and 2 years after diagnosis were obtained. The main outcome was all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At diagnosis, mean (SD) age was 52 (12) years, 56% were male, 52% were current or ex-smokers, mean BMI was 33\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , and 66% were obese. Normal weight and overweight patients experienced a small but significant reduction in body weight 6 months before diagnosis. Among all categories of obese patients, consistently increasing body weight was observed within the same time window.\n                    <\/jats:p>\n                    <jats:p>\n                      Among patients who did not lose body weight pre-diagnosis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009117,469), compared with the grade 1 obese, normal weight patients had 35% (95% CI of HR: 1.17, 1.55) significantly higher adjusted mortality risk. However, among patients experiencing weight loss before diagnosis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927,589), BMI at diagnosis was not associated with mortality risk (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Weight loss before the diagnosis of T2DM was not associated with the observed increased mortality risk in normal weight patients with T2DM. This emphasises the importance of addressing risk factors post diagnosis for excess mortality in this group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41387-018-0042-0","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T12:31:51Z","timestamp":1527683511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Weight loss and mortality risk in patients with different adiposity at diagnosis of type 2 diabetes: a longitudinal cohort study"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1206-6210","authenticated-orcid":false,"given":"Ebenezer S. Adjah","family":"Owusu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayukh","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjoy K.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"42_CR1","first-page":"581","volume":"308","author":"MR Carnethon","year":"2012","unstructured":"Carnethon, M. R. et al. Association of weight status with mortality in adults with incident diabetes. JAMA 308, 581\u2013590 (2012).","journal-title":"JAMA"},{"key":"42_CR2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2337\/dc11-2407","volume":"35","author":"P Kokkinos","year":"2012","unstructured":"Kokkinos, P. et al. BMI\u2013mortality paradox and fitness in African American and Caucasian men with type 2 diabetes. Diabetes Care 35, 1021\u20131027 (2012).","journal-title":"Diabetes Care"},{"key":"42_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2337\/dc12-0944","volume":"36","author":"J Logue","year":"2013","unstructured":"Logue, J. et al. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 36, 887\u2013893 (2013).","journal-title":"Diabetes Care"},{"key":"42_CR4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1464-5491.2006.01838.x","volume":"23","author":"HE Mulnier","year":"2006","unstructured":"Mulnier, H. E. et al. Mortality in people with type 2 diabetes in the UK. Diabet. Med.: J. Br. Diabet. Assoc. 23, 516\u2013521 (2006).","journal-title":"Diabet. Med.: J. Br. Diabet. Assoc."},{"key":"42_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/dom.12217","volume":"16","author":"G Thomas","year":"2014","unstructured":"Thomas, G. et al. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes. Metab. 16, 317\u2013325 (2014).","journal-title":"Diabetes Obes. Metab."},{"key":"42_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1464-5491.2009.02672.x","volume":"26","author":"A Weiss","year":"2009","unstructured":"Weiss, A., Boaz, M., Beloosesky, Y., Kornowski, R. & Grossman, E. Body mass index and risk of all-cause and cardiovascular mortality in hospitalized elderly patients with diabetes mellitus. Diabet. Med.: J. Br. Diabet. Assoc. 26, 253\u2013259 (2009).","journal-title":"Diabet. Med.: J. Br. Diabet. Assoc."},{"key":"42_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.ijo.802199","volume":"27","author":"G Zoppini","year":"2003","unstructured":"Zoppini, G. et al. Body mass index and the risk of mortality in type II diabetic patients from Verona. Int. J. Obes. 27, 281\u2013285 (2003).","journal-title":"Int. J. Obes."},{"key":"42_CR8","doi-asserted-by":"crossref","unstructured":"Zhao W., et al. Body mass index and the risk of all-cause mortality among patients with Type 2 diabetes. Circulation. 130, 2143\u20132151 (2014). Published online before print.","DOI":"10.1161\/CIRCULATIONAHA.114.009098"},{"key":"42_CR9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.7326\/M14-1551","volume":"162","author":"P Costanzo","year":"2015","unstructured":"Costanzo, P. et al. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann. Intern. Med. 162, 610\u2013618 (2015).","journal-title":"Ann. Intern. Med."},{"key":"42_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1304501","volume":"370","author":"DK Tobias","year":"2014","unstructured":"Tobias, D. K. et al. Body-mass index and mortality among adults with incident type 2 diabetes. New Engl. J. Med. 370, 233\u2013244 (2014).","journal-title":"New Engl. J. Med."},{"key":"42_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/CRD.0000000000000004","volume":"22","author":"A Goyal","year":"2014","unstructured":"Goyal, A., Nimmakayala, K. R. & Zonszein, J. Is there a paradox in obesity? Cardiol. Rev. 22, 163\u2013170 (2014).","journal-title":"Cardiol. Rev."},{"key":"42_CR12","doi-asserted-by":"publisher","first-page":"e0122219","DOI":"10.1371\/journal.pone.0122219","volume":"10","author":"N de Fine Olivarius","year":"2015","unstructured":"de Fine Olivarius, N., Siersma, V. D., Koster-Rasmussen, R., Heitmann, B. L. & Waldorff, F. B. Weight changes following the diagnosis of type 2 diabetes: the impact of recent and past weight history before diagnosis. Results from the Danish Diabetes Care in General Practice (DCGP) study. PloS ONE 10, e0122219 (2015).","journal-title":"PLOS One"},{"key":"42_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/jdi.12308","volume":"6","author":"Y Heianza","year":"2015","unstructured":"Heianza, Y. et al. Trajectory of body mass index before the development of type 2 diabetes in Japanese men: Toranomon Hospital Health Management Center Study 15. J. Diabetes Investig. 6, 289\u2013294 (2015).","journal-title":"J. Diabetes Investig."},{"key":"42_CR14","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2337\/diacare.24.11.1917","volume":"24","author":"HC Looker","year":"2001","unstructured":"Looker, H. C., Knowler, W. C. & Hanson, R. L. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 24, 1917\u20131922 (2001).","journal-title":"Diabetes Care"},{"key":"42_CR15","doi-asserted-by":"publisher","first-page":"e1001602","DOI":"10.1371\/journal.pmed.1001602","volume":"11","author":"D Vistisen","year":"2014","unstructured":"Vistisen, D. et al. Patterns of obesity development before the diagnosis of type 2 diabetes: The Whitehall II Cohort Study. PLOS Med. 11, e1001602 (2014).","journal-title":"PLOS Med."},{"key":"42_CR16","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2337\/diacare.22.8.1266","volume":"22","author":"SG Wannamethee","year":"1999","unstructured":"Wannamethee, S. G. & Shaper, A. G. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22, 1266\u20131272 (1999).","journal-title":"Diabetes Care"},{"key":"42_CR17","unstructured":"IMS Health Incorporated. The Health Improvement Network (THIN) database London: IMS Health Incorporated. http:\/\/www.csdmruk.imshealth.com\/index.html (2017)."},{"key":"42_CR18","unstructured":"THIN Database Research Team. THIN database London: UCL. https:\/\/www.ucl.ac.uk\/pcph\/research-groups-themes\/thin-pub (2017)."},{"key":"42_CR19","first-page":"251","volume":"19","author":"BT Blak","year":"2011","unstructured":"Blak, B. T., Thompson, M., Dattani, H. & Bourke, A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform. Prim. Care 19, 251\u2013255 (2011).","journal-title":"Inform. Prim. Care"},{"key":"42_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/pds.2203","volume":"20","author":"MR Denburg","year":"2011","unstructured":"Denburg, M. R., Haynes, K., Shults, J., Lewis, J. D. & Leonard, M. B. Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease. Pharmacoepidemiol. Drug Saf. 20, 1138\u20131149 (2011).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"42_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0007-0785(05)80418-1","volume":"80","author":"J Read","year":"1991","unstructured":"Read, J. The Read clinical classification (Read codes). Br. Homoeopath. J. 80, 14\u201320 (1991).","journal-title":"Br. Homoeopath. J."},{"key":"42_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"E Herrett","year":"2010","unstructured":"Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L. & Hall, A. J. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br. J. Clin. Pharmacol. 69, 4\u201314 (2010).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"42_CR23","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"NF Khan","year":"2010","unstructured":"Khan, N. F., Harrison, S. E. & Rose, P. W. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br. J. Gen. Pract. 60, e128\u2013e136 (2010).","journal-title":"Br. J. Gen. Pract."},{"key":"42_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/1875036201710010016","volume":"10","author":"ES Owusu Adjah","year":"2017","unstructured":"Owusu Adjah E. S., Montvida O., Agbeve J., Paul S. K. Data mining approach to identify disease cohorts from primary care electronic medical records: a case of diabetes mellitus. Open Bioinform. J. 10, 16\u201327 (2017).","journal-title":"Open Bioinform. J."},{"key":"42_CR25","unstructured":"Townsend P., Phillimore P., Beattie A. Health and deprivation: inequality and the north (Croom Helm, London, 1988)."},{"key":"42_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation.","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157 (2004).","journal-title":"Lancet"},{"key":"42_CR27","doi-asserted-by":"publisher","first-page":"e010836","DOI":"10.1136\/bmjopen-2015-010836","volume":"6","author":"LS Aucott","year":"2016","unstructured":"Aucott, L. S. et al. Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study. BMJ Open 6, e010836 (2016).","journal-title":"BMJ Open"},{"key":"42_CR28","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2337\/diacare.28.6.1526","volume":"28","author":"FX Pi-Sunyer","year":"2005","unstructured":"Pi-Sunyer, F. X. Weight loss in type 2 diabetic patients. Diabetes Care 28, 1526\u20131527 (2005).","journal-title":"Diabetes Care"},{"key":"42_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s11886-013-0446-3","volume":"16","author":"MR Carnethon","year":"2014","unstructured":"Carnethon, M. R., Rasmussen-Torvik, L. J. & Palaniappan, L. The obesity paradox in diabetes. Curr. Cardiol. Rep. 16, 446 (2014).","journal-title":"Curr. Cardiol. Rep."},{"key":"42_CR30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/hrt.2008.150524","volume":"95","author":"M Khalangot","year":"2009","unstructured":"Khalangot, M., Tronko, M., Kravchenko, V., Kulchinska, J. & Hu, G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: A large prospective study in Ukraine. Heart (Br. Card. Soc.). 95, 454\u2013460 (2009).","journal-title":"Heart (Br. Card. Soc.)."},{"key":"42_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/EDE.0b013e31828c776c","volume":"24","author":"HR Banack","year":"2013","unstructured":"Banack, H. R. & Kaufman, J. S. The \u201cObesity Paradox\u201d explained. Epidemiol. (Camb., Mass). 24, 461\u2013462 (2013).","journal-title":"Epidemiol. (Camb., Mass)."},{"key":"42_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.annepidem.2015.02.008","volume":"25","author":"HR Banack","year":"2015","unstructured":"Banack, H. R. & Kaufman, J. S. Does selection bias explain the obesity paradox among individuals with cardiovascular disease? Ann. Epidemiol. 25, 342\u2013349 (2015).","journal-title":"Ann. Epidemiol."},{"issue":"Supplement 2","key":"42_CR33","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.2337\/dcS13-2023","volume":"36","author":"V Hainer","year":"2013","unstructured":"Hainer, V. & Aldhoon-Hainerov\u00e1, I. Obesity paradox does exist. Diabetes Care 36(Supplement 2), S276\u2013S281 (2013).","journal-title":"Diabetes Care"},{"key":"42_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ejcn.2015.45","volume":"70","author":"M Batterham","year":"2016","unstructured":"Batterham, M., Tapsell, L. C. & Charlton, K. E. Baseline characteristics associated with different BMI trajectories in weight loss trials: a case for better targeting of interventions. Eur. J. Clin. Nutr. 70, 207\u2013211 (2016).","journal-title":"Eur. J. Clin. Nutr."},{"key":"42_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.14236\/jhi.v22i2.79","volume":"22","author":"S de Lusignan","year":"2015","unstructured":"de Lusignan, S. et al. An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR). J. Innov. Health Inform. 22, 255\u2013264 (2015).","journal-title":"J. Innov. Health Inform."},{"key":"42_CR36","first-page":"103","volume":"20","author":"S de Lusignan","year":"2012","unstructured":"de Lusignan, S. et al. Call for consistent coding in diabetes mellitus using the Royal College of General Practitioners and NHS pragmatic classification of diabetes. Inform. Prim. Care. 20, 103\u2013113 (2012).","journal-title":"Inform. Prim. Care."},{"key":"42_CR37","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1742-1241.2012.02979.x","volume":"66","author":"N Hassan Sadek","year":"2012","unstructured":"Hassan Sadek, N. et al. Evaluating tools to support a new practical classification of diabetes: excellent control may represent misdiagnosis and omission from disease registers is associated with worse control. Int. J. Clin. Pract. 66, 874\u2013882 (2012).","journal-title":"Int. J. Clin. Pract."},{"key":"42_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1464-5491.2011.03457.x","volume":"29","author":"AR Sadek","year":"2012","unstructured":"Sadek, A. R., van Vlymen, J., Khunti, K. & de Lusignan, S. Automated identification of miscoded and misclassified cases of diabetes from computer records. Diabet. Med.: a J. Br. Diabet. Assoc. 29, 410\u2013414 (2012).","journal-title":"Diabet. Med.: a J. Br. Diabet. Assoc."}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-018-0042-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-018-0042-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-018-0042-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T06:01:48Z","timestamp":1671516108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-018-0042-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1038\/s41387-018-0042-0","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]},"assertion":[{"value":"10 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.K.P. has acted as a consultant and speaker for Novartis, GI Dynamics, Roche, AstraZeneca, Guangzhou Zhongyi Pharmaceutical and Amylin Pharmaceuticals LLC. He has received grants in support of investigator and investigator-initiated clinical studies from Merck, Novo Nordisk, AstraZeneca, Hospira, Amylin Pharmaceuticals, Sanofi-Avensis, and Pfizer. J.E.S has received honoraria for advisory boards and lectures from AstraZeneca, BGP Products, Boehringer Ingelheim, Novartis, Janssen, Lilly, Novartis, Novo Nordisk, MSD, and Sanofi. K.K. has acted as a consultant, speaker or received funds for research from Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Janssen, Astra Zeneca and Boehringer Ingelheim, Roche and Servere. The other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"37"}}